MedPath

Effect of tacrolimus drops and PRP in the treatment of chronic dry eye

Phase 2
Recruiting
Conditions
Dry eye syndrome.
Dry eye syndrome
H04.12
Registration Number
IRCT20211011052725N1
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
18
Inclusion Criteria

Patients over 18 years
Corneal staining
Schirmer test is less than 5 mm in 5 minutes
BUT test is less than 5 seconds.

Exclusion Criteria

Pregnancy
Lactation
Pregnancy, lactation, history of glaucoma and previous surgery and trauma
Use of eye drops other than artificial tears, and use of contact lenses.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
BUT test (Fluorescein disappears from Fornix). Timepoint: One week, one month and three months after starting treatment. Method of measurement: Clinical examination of the patient - per second.;Corneal staining. Timepoint: One week, one month and three months after starting treatment. Method of measurement: Clinical examination of the patient.;Schirmer test. Timepoint: One week, one month and three months after starting treatment. Method of measurement: Clinical examination of the patient - In millimeters per minute.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath